The Aegate medicines authentication and verification programme will now process to the live scanning of medicines at point of dispense in Cyprus, thereby promoting patient safety and undermining trafficking of counterfeit and expired medicines.
The Aegate model, yet tested in European countries in the last eight years, has had a positive impact on both pharmacies and suppliers. 1.8 million medicines have already been stopped.
Since the introduction of the EU Falsified Medicines Directive, medicines must have been uniquely serialized, protected by tamper-proof seals and their authenticity verified before distribution.
Aegate is a European company operating throughout Europe and aiming at protecting patients against counterfeit, falsified, recalled and expired medicines. 3.3 billion medicines have been scanned so far in Europe and an average rate of 200,000 transactions per hour across 20,000 dispensing points.
Source: PR NewswireBack to previous